Insufficient use of lipid-lowering drugs and measurement of serum cholesterol among patients with a history of myocardial infarction
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Insufficient use of lipid-lowering drugs and measurement of serum cholesterol among patients with a history of myocardial infarction. / Larsen, John; Andersen, Morten; Bjerrum, Lars; Kragstrup, Jakob; Gram, Lars F.
In: European Journal of Preventive Cardiology, Vol. 10, No. 1, 01.01.2003, p. 61-64.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Insufficient use of lipid-lowering drugs and measurement of serum cholesterol among patients with a history of myocardial infarction
AU - Larsen, John
AU - Andersen, Morten
AU - Bjerrum, Lars
AU - Kragstrup, Jakob
AU - Gram, Lars F.
PY - 2003/1/1
Y1 - 2003/1/1
N2 - Background The effect of lipid-lowering drugs (LLDs) on coronary heart disease is well documented, particularly in patients with established ischaemic heart disease. However, intensity of the use of these drugs is low. The aim of this linkage study was to analyse the use of serum cholesterol measurements and LLDs among patients with a history of myocardial infarction (MI) in a Danish population. Methods Information on serum cholesterol values was retrieved from the hospital's Department of Clinical Chemistry for all patients from the Odense municipality and four surrounding municipalities (213 868 inhabitants) hospitalised at Odense University Hospital for MI between1994–1997. Information on LLD use was obtained from a prescription database. Only patients alive at discharge were included in the investigation. The total observation period was from 1993–1998. Results In all, 1018 patients were eligible for observation and 39% of the patients who met the criteria for LLD reimbursement (MI and serum cholesterol =5.4 mmol/L) started treatment. Relatively more males than females and relatively more patients under the age of 70 years were treated. Patients above the age of 70 years were prescribed these drugs at a slower rate. Conclusions More attention to the insufficient use of lipid-lowering drug treatment in patients with established coronary heart disease is needed.
AB - Background The effect of lipid-lowering drugs (LLDs) on coronary heart disease is well documented, particularly in patients with established ischaemic heart disease. However, intensity of the use of these drugs is low. The aim of this linkage study was to analyse the use of serum cholesterol measurements and LLDs among patients with a history of myocardial infarction (MI) in a Danish population. Methods Information on serum cholesterol values was retrieved from the hospital's Department of Clinical Chemistry for all patients from the Odense municipality and four surrounding municipalities (213 868 inhabitants) hospitalised at Odense University Hospital for MI between1994–1997. Information on LLD use was obtained from a prescription database. Only patients alive at discharge were included in the investigation. The total observation period was from 1993–1998. Results In all, 1018 patients were eligible for observation and 39% of the patients who met the criteria for LLD reimbursement (MI and serum cholesterol =5.4 mmol/L) started treatment. Relatively more males than females and relatively more patients under the age of 70 years were treated. Patients above the age of 70 years were prescribed these drugs at a slower rate. Conclusions More attention to the insufficient use of lipid-lowering drug treatment in patients with established coronary heart disease is needed.
KW - coronary heart disease
KW - linkage study
KW - lipid-lowering drugs
KW - serum cholesterol
UR - http://www.scopus.com/inward/record.url?scp=84992777488&partnerID=8YFLogxK
U2 - 10.1177/174182670301000110
DO - 10.1177/174182670301000110
M3 - Journal article
AN - SCOPUS:84992777488
VL - 10
SP - 61
EP - 64
JO - European Journal of Preventive Cardiology
JF - European Journal of Preventive Cardiology
SN - 2047-4873
IS - 1
ER -
ID: 201128465